Concourse Financial Group Securities’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 10662 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 10942 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 10852 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 10699 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 10721 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 10850 |
|
|
2023
Q3 | – | Sell |
-25
| Closed | -$8 | – | 10892 |
|
|
2023
Q2 | $8 | Hold |
25
| – | – | ﹤0.01% | 2323 |
|
|
2023
Q1 | $9 | Buy |
+25
| New | +$9 | ﹤0.01% | 2352 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 10592 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 10407 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 10190 |
|
|
2022
Q1 | – | Sell |
-2,050
| Closed | -$10K | – | 9945 |
|
|
2021
Q4 | $10K | Hold |
2,050
| – | – | ﹤0.01% | 1871 |
|
|
2021
Q3 | $16K | Hold |
2,050
| – | – | ﹤0.01% | 1734 |
|
|
2021
Q2 | $20K | Hold |
2,050
| – | – | ﹤0.01% | 1654 |
|
|
2021
Q1 | $17K | Hold |
2,050
| – | – | ﹤0.01% | 1616 |
|
|
2020
Q4 | $14K | Sell |
2,050
-300
| -13% | -$2.05K | ﹤0.01% | 1588 |
|
|
2020
Q3 | $26K | Buy |
2,350
+300
| +15% | +$3.32K | ﹤0.01% | 1283 |
|
|
2020
Q2 | $13K | Buy |
+2,050
| New | +$13K | ﹤0.01% | 1431 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 6702 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 6610 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 6450 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 6420 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 6278 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 6192 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 6029 |
|